Short answer: Neither Germany nor Austria bans research peptides as substances, but both treat any product intended or presented for human use as a medicine. In Germany an unauthorised medicine may not be brought in by post for a private person (section 73 AMG), which Zoll enforces, and a short list of peptides also falls under the Anti-Doping-Gesetz above set quantities. Austria goes further: the BASG classifies web-shop "peptides" as illegal medicines whose import is prohibited, and the AWEG covers parcels from other EU states. A vial sold and used as a laboratory reagent is the only position the law leaves open.
Disclosure: Peps and Protocols is published by the team behind Vitality Peps. Vendor facts below were checked on each vendor's public website on the date shown, and the criteria are the same for every vendor. This article is general information, not legal advice; rules change and enforcement varies, so check the current position with a qualified adviser in your country.
No German law lists research peptides as controlled substances. The question is whether a vial is an Arzneimittel under section 2 of the Arzneimittelgesetz: a substance intended for use on the human body to treat disease, or one that can be administered to humans to restore, correct or influence physiological functions. A peptide sold as a laboratory reagent is a chemical; the same peptide sold for injection is a medicine.
Once a product is a medicine, the rest of the AMG follows: section 21 requires a marketing authorisation, section 43 reserves supply to pharmacies, and section 95 criminalises trading prescription-only medicines outside pharmacies. None of the common research peptides, BPC-157, TB-500, GHK-Cu, Semax or Selank among them, holds a BfArM or EMA authorisation. Zoll adds that the law of the seller's country does not matter; only the German classification counts.
No. BPC-157 has no marketing authorisation in Germany or anywhere in the EU, so no pharmacy can dispense it as a finished medicine and no web shop can lawfully sell it for human use. It can be sold as a research reagent, which is how EU suppliers list it. For competitive athletes, WADA's 2026 Prohibited List names BPC-157 under S0, non-approved substances.
"Research use only" protects a supplier that behaves like a reagent supplier, and nobody else; the BASG's 27 May 2026 notice, discussed below, says the label is legally irrelevant once a shop's context shows human use.
Prescription status is not the issue; authorisation is. Section 73(1) AMG bans bringing into Germany any medicine that needs an authorisation but lacks one, and Zoll states that private persons "may not obtain medicines from abroad by post or courier". A parcel from outside the EU is an import, is cleared by Zoll, and any suspected breach is passed to the state medicines authority.
Section 97(2) no. 8 AMG makes bringing such a medicine in an administrative offence with a fine of up to 25,000 euro, and the goods are not released. Zoll press releases show it being applied to recipients: in February 2026 a Friedrichshafen unit opened 18 proceedings against parcel recipients after checking foreign post, and in July 2026 the Braunschweig main customs office announced Bannbruch proceedings under section 372 Abgabenordnung with section 73(1) AMG against a parcel recipient.
Customs-wise, yes: a parcel from the Netherlands or Spain is not an import, needs no declaration and pays no duty. Legally the AMG still applies. Zoll's page on intra-EU shipments states that private persons may not order medicines by post from another member state either, except from an approved mail-order pharmacy. An EU parcel removes the border check, not the classification question.
A reagent sold by an EU supplier without health claims or injection accessories moves under free movement of goods and arrives in days rather than weeks. Vitality Peps dispatches from Spain and the Netherlands within 24 hours with delivery in 1 to 3 business days, per its shipping page; its guide on buying research peptides in Europe covers cold chain.
The Anti-Doping-Gesetz adds a criminal offence for a defined list. Section 2(3) prohibits acquiring, possessing or bringing into Germany a substance listed in the Anlage to the Act "in nicht geringer Menge" for the purpose of doping in sport; section 4(1) no. 3 sets up to three years' imprisonment. Three elements must coincide: a listed substance, a quantity above the Dopingmittel-Mengen-Verordnung threshold, and a doping purpose in sport.
The Anlage, as amended in 2023, lists growth hormone releasing factors and secretagogues, naming CJC-1295, sermorelin, mod-GRF, ipamorelin, MK-677, GHRP-2, GHRP-6 and hexarelin, fragments such as AOD-9604, IGF-1 and MGF, and "Thymosin-beta-4 und seine Derivate, zum Beispiel TB-500". The DmMV thresholds are 180 mg for the GHRH group, 150 mg for secretagogues, 1.5 mg for GHRPs and 100 mg for thymosin beta-4 derivatives. BPC-157, GHK-Cu, Semax, Selank, Epithalon, PT-141, KPV and MOTS-c do not appear.
Yes. Austria's Arzneiwareneinfuhrgesetz 2010 covers both "Einfuhr" from third countries and "Verbringen" from EEA states. Section 3 allows either only with an import certificate or a notification to the BASG, section 4 limits applicants to pharmacies and licensed companies, and the BASG states that private persons cannot file at all. The only private route, section 11(1) no. 7, runs through an Austrian pharmacy, capped at three retail packs.
The BASG notice of 27 May 2026 states that many web-shop "peptides" are medicines without authorisation, that their placing on the market and import into Austria are prohibited, and that buyers as well as sellers "must expect legal consequences, for example a report". Under section 21 AWEG an import without certificate or a transfer without notification carries a fine of up to 3,600 euro, 7,260 euro on repeat, and the goods can be forfeited. Reagents that are not medicines fall outside the AWEG.
German pharmacies sell sterilised Wasser für Injektionszwecke, an authorised medicine such as Ampuwa, in single-use ampoules. Bacteriostatic water, preserved with 0.9 per cent benzyl alcohol for repeated laboratory withdrawals, is not a standard pharmacy line in Germany and comes from research suppliers as a laboratory reagent. Delivery from EU stock to Germany takes 1 to 3 business days.
On payment, checked on 3 September 2026, Vitality Peps lists card, Apple Pay, Google Pay and crypto; SEPA transfer is the other rail German buyers commonly meet, and card payment preserves chargeback rights that crypto removes. Batch-level Janoshik Analytical reports are on the Vitality Peps lab results page; the guide to reading a peptide COA shows what to match against the vial.
| Scenario | What the law says | Source |
|---|---|---|
| Reagent from an EU supplier, no health claims, no instructions for human use | Not a medicine by presentation; free movement, no customs step | AMG s. 2; Directive 2001/83/EC art. 1(2) |
| Unauthorised medicine by post from outside the EU | Verbringungsverbot; fine up to 25,000 euro; goods withheld | AMG s. 73(1), s. 97(2) no. 8; zoll.de |
| Listed substance above threshold (TB-500 over 100 mg) held for doping in sport | Criminal offence, up to three years | AntiDopG s. 2(3), s. 4(1) no. 3; DmMV |
| Medicine ordered by an Austrian private person, from the EU or beyond | Prohibited outside the pharmacy route; fine up to 3,600 euro; forfeiture | AWEG ss. 3, 4, 11, 21; BASG notice, 27 May 2026 |
As a laboratory reagent from an EU research supplier, yes; it is not a controlled substance and not on the AntiDopG Anlage. As a medicine for human use, no: it has no authorisation, and bringing an unauthorised medicine into Germany by post breaches section 73 AMG. Presentation and use decide which you are buying.
The BASG treats web-shop peptides presented for human use as illegal medicines whose import is prohibited, and warns that buyers may be reported. A reagent that is not a medicine is outside the AWEG, but the BASG judges the whole context of the shop, not the label. Austria is stricter than Germany.
Zoll withholds the parcel, reports the suspected breach to the state medicines authority and, in published cases, opens proceedings against the recipient: an administrative fine of up to 25,000 euro under section 97 AMG, or a criminal file where Bannbruch or the AntiDopG is alleged. The goods are not returned.
GHK-Cu is not on the AntiDopG Anlage, and as Copper Tripeptide-1 it is listed in the EU CosIng inventory as a skin-conditioning cosmetic ingredient. As an injectable it is an unauthorised medicine like any other peptide presented for human use, so section 73 AMG applies to postal imports. Sold as a research reagent, it can be bought from EU suppliers.
Germany allows reagents and bars postal imports of unauthorised medicines; Austria adds the AWEG and an explicit BASG warning to buyers; Switzerland is outside the EU, so parcels are imports. In a joint action on 22 June 2026 Swissmedic, the BAZG and Swiss Sport Integrity checked 46 peptide parcels and withheld 23.